We are live on ! Find out more
GDRX icon

GoodRx Holdings

159 hedge funds and large institutions have $633M invested in GoodRx Holdings in 2022 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 41 increasing their positions, 56 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

49% more call options, than puts

Call options by funds: $4.72M | Put options by funds: $3.17M

0.67% less ownership

Funds ownership: 165.38%164.7% (-0.67%)

3% less capital invested

Capital invested by funds: $652M → $633M (-$19.2M)

12% less funds holding

Funds holding: 180159 (-21)

27% less repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 56

39% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 44

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

Holders
159
Holders Change
-21
Holders Change %
-11.67%
% of All Funds
2.55%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
27
Increased
41
Reduced
56
Closed
44
Calls
$4.72M
Puts
$3.17M
Net Calls
+$1.55M
Net Calls Change
+$1.35M

GDRX Hedge Fund Activity: Q4 2022 in Review

159 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q4 2022, worth a combined $633M — down 2.9% from $652M a quarter earlier.

Sellers outnumbered buyers: 44 funds closed out of GDRX and 27 opened new positions — a net loss of 17 holders — while 56 trimmed existing stakes and 41 added.

The largest buyer was Millennium Management, adding an estimated $15.8M. The largest seller was Light Street Capital Management, exiting entirely with an estimated $19.6M sold.

  • 159 institutional investors held GoodRx Holdings (GDRX) as of Q4 2022, down from 180 in Q3 2022.
  • Funds reported $633M of GoodRx Holdings stock for Q4 2022, down 2.9% quarter-over-quarter.
  • 27 funds opened new GoodRx Holdings positions in Q4 2022 and 44 closed out, a net change of -17 holders.
  • The largest GoodRx Holdings buyer in Q4 2022 was Millennium Management, an estimated $15.8M added.
  • The largest GoodRx Holdings seller in Q4 2022 was Light Street Capital Management, an estimated $19.6M sold.

Based on aggregated 13F filings for Q4 2022.